These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

489 related articles for article (PubMed ID: 25522241)

  • 1. HOXD-AS1 is a novel lncRNA encoded in HOXD cluster and a marker of neuroblastoma progression revealed via integrative analysis of noncoding transcriptome.
    Yarmishyn AA; Batagov AO; Tan JZ; Sundaram GM; Sampath P; Kuznetsov VA; Kurochkin IV
    BMC Genomics; 2014; 15 Suppl 9(Suppl 9):S7. PubMed ID: 25522241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The noncoding RNA HOXD-AS1 is a critical regulator of the metastasis and apoptosis phenotype in human hepatocellular carcinoma.
    Lu S; Zhou J; Sun Y; Li N; Miao M; Jiao B; Chen H
    Mol Cancer; 2017 Jul; 16(1):125. PubMed ID: 28724429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Silencing of long noncoding RNA HOXD-AS1 inhibits proliferation, cell cycle progression, migration and invasion of hepatocellular carcinoma cells through MEK/ERK pathway.
    Sun J; Guo Y; Bie B; Zhu M; Tian H; Tian J; Li J; Yang Y; Ji F; Kong G; Li Z
    J Cell Biochem; 2020 Jan; 121(1):443-457. PubMed ID: 31231887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nuclear lncRNA HOXD-AS1 suppresses colorectal carcinoma growth and metastasis via inhibiting HOXD3-induced integrin β3 transcriptional activating and MAPK/AKT signalling.
    Yang MH; Zhao L; Wang L; Ou-Yang W; Hu SS; Li WL; Ai ML; Wang YQ; Han Y; Li TT; Ding YQ; Wang S
    Mol Cancer; 2019 Mar; 18(1):31. PubMed ID: 30823921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long noncoding RNA ABHD11-AS1 predicts the prognosis of pancreatic cancer patients and serves as a promoter by activating the PI3K-AKT pathway.
    Qiao X; Lv SX; Qiao Y; Li QP; Ye B; Wang CC; Miao L
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8630-8639. PubMed ID: 30575903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthetic tetracycline-controllable shRNA targeting long non-coding RNA HOXD-AS1 inhibits the progression of bladder cancer.
    Li J; Zhuang C; Liu Y; Chen M; Chen Y; Chen Z; He A; Lin J; Zhan Y; Liu L; Xu W; Zhao G; Guo Y; Wu H; Cai Z; Huang W
    J Exp Clin Cancer Res; 2016 Jun; 35(1):99. PubMed ID: 27328915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AFAP1-AS1, a long noncoding RNA upregulated in lung cancer and promotes invasion and metastasis.
    Zeng Z; Bo H; Gong Z; Lian Y; Li X; Li X; Zhang W; Deng H; Zhou M; Peng S; Li G; Xiong W
    Tumour Biol; 2016 Jan; 37(1):729-37. PubMed ID: 26245991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. lncRNA HOXD-AS1 Regulates Proliferation and Chemo-Resistance of Castration-Resistant Prostate Cancer via Recruiting WDR5.
    Gu P; Chen X; Xie R; Han J; Xie W; Wang B; Dong W; Chen C; Yang M; Jiang J; Chen Z; Huang J; Lin T
    Mol Ther; 2017 Aug; 25(8):1959-1973. PubMed ID: 28487115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long non-coding RNA HOXD-AS1 in cancer.
    Li L; Wang Y; Zhang X; Huang Q; Diao Y; Yin H; Liu H
    Clin Chim Acta; 2018 Dec; 487():197-201. PubMed ID: 30290157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HOXD-AS1 is a predictor of clinical progression and functions as an oncogenic lncRNAs in papillary thyroid cancer.
    Xu K; Feng Y
    J Cell Biochem; 2019 Apr; 120(4):5326-5332. PubMed ID: 30317670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of prognostic long noncoding RNAs associated with spontaneous regression of neuroblastoma.
    Meng X; Fang E; Zhao X; Feng J
    Cancer Med; 2020 Jun; 9(11):3800-3815. PubMed ID: 32216054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. STAT3-mediated upregulation of lncRNA HOXD-AS1 as a ceRNA facilitates liver cancer metastasis by regulating SOX4.
    Wang H; Huo X; Yang XR; He J; Cheng L; Wang N; Deng X; Jin H; Wang N; Wang C; Zhao F; Fang J; Yao M; Fan J; Qin W
    Mol Cancer; 2017 Aug; 16(1):136. PubMed ID: 28810927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HOXD-AS1 promotes the epithelial to mesenchymal transition of ovarian cancer cells by regulating miR-186-5p and PIK3R3.
    Dong S; Wang R; Wang H; Ding Q; Zhou X; Wang J; Zhang K; Long Y; Lu S; Hong T; Ren H; Wong K; Sheng X; Wang Y; Zeng Y
    J Exp Clin Cancer Res; 2019 Mar; 38(1):110. PubMed ID: 30823895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of genomic architecture in the expression dynamics of long noncoding RNAs during differentiation of human neuroblastoma cells.
    Batagov AO; Yarmishyn AA; Jenjaroenpun P; Tan JZ; Nishida Y; Kurochkin IV
    BMC Syst Biol; 2013 Oct; 7 Suppl 3(Suppl 3):S11. PubMed ID: 24555823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HOXD-AS1 facilitates cell migration and invasion as an oncogenic lncRNA by competitively binding to miR-877-3p and upregulating FGF2 in human cervical cancer.
    Chen S; Li K
    BMC Cancer; 2020 Sep; 20(1):924. PubMed ID: 32977766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HOXD-AS1 confers cisplatin resistance in gastric cancer through epigenetically silencing PDCD4 via recruiting EZH2.
    Ye Y; Yang S; Han Y; Sun J; Xv L; Wu L; Ming L
    Open Biol; 2019 Sep; 9(9):190068. PubMed ID: 31551012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA TP73-AS1 Promotes Cell Proliferation and Inhibits Cell Apoptosis in Clear Cell Renal Cell Carcinoma Through Repressing KISS1 Expression and Inactivation of PI3K/Akt/mTOR Signaling Pathway.
    Liu G; Zhao X; Zhou J; Cheng X; Ye Z; Ji Z
    Cell Physiol Biochem; 2018; 48(1):371-384. PubMed ID: 30016766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knockdown of long non-coding RNA HOXD-AS1 inhibits gastric cancer cell growth via inactivating the JAK2/STAT3 pathway.
    Zheng L; Chen J; Zhou Z; He Z
    Tumour Biol; 2017 May; 39(5):1010428317705335. PubMed ID: 28475004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Co-expression analysis identifies long noncoding RNA SNHG1 as a novel predictor for event-free survival in neuroblastoma.
    Sahu D; Hsu CL; Lin CC; Yang TW; Hsu WM; Ho SY; Juan HF; Huang HC
    Oncotarget; 2016 Sep; 7(36):58022-58037. PubMed ID: 27517149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive analysis of differential expression profiles of mRNAs and lncRNAs and identification of a 14-lncRNA prognostic signature for patients with colon adenocarcinoma.
    Xing Y; Zhao Z; Zhu Y; Zhao L; Zhu A; Piao D
    Oncol Rep; 2018 May; 39(5):2365-2375. PubMed ID: 29565464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.